Gene · 1063
CENPF: centromere protein F
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CENPF: centromere protein F. Genes, record 1063. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1063
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P49454 | Centromere protein F | 3,114 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents33
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 40830 | P49454 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 8138 | P49454 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 8294 | P49454 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 5373 | P49454 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 8294 | P49454 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 8138 | P49454 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 5373 | P49454 | Espacenet |
| US 12097221 B2 | 2024-09-24 | 12 | P49454 | Espacenet |
| JP 2022141755 A | 2022-09-29 | 201 | P49454 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 13889 | P49454 | Espacenet |
1 to 10 of 33
See all 33 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,492
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CENPF papers | Newest fiscal year |
|---|---|---|---|
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 17 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 16 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 10 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 8 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 5 | 2025 |
| R01GM074215 | Kinetochore Specification and Function | 5 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 4 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 4 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 4 | 2025 |
| P30EY008126 | Core Grant in Vision Research | 4 | 2025 |
1 to 10 of 1,492Source NIH's project files
See all 1,492 nih grantsPapers2,501
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High Infiltration Level of a Prognostic Improvement Associated T Cells Is Favorable for the Prognosis of Patients with Gastric Adenocarcinoma. | Digestion | 2026 | 42771562 | PubTator, text mining | PubMed |
| KDM1A/HDAC2-driven epigenetic dysregulation maintains a drug-resistant, relapse-initiating glioblastoma cell niche at the peri-tumoral margin. | Biochem Pharmacol | 2026 | 42685875 | PubTator, text mining | PubMed |
| PROFET predicts continuous gene expression dynamics from scRNA-seq data to elucidate heterogeneity of cancer treatment responses. | Cell Syst | 2026 | 42664975 | PubTator, text mining | PubMed |
| Immune-related gene signature for predicting biochemical recurrence after RP in prostate cancer subtypes. | Discov Oncol | 2026 | 42635880 | PubTator, text mining | PubMed |
| Unveiling immune-related gene signatures in triple negative breast cancer through integrated transcriptomic analysis. | Biomedicine (Taipei) | 2026 | 42483440 | PubTator, text mining | PubMed |
| Strømme syndrome: the clinical and molecular spectrum associated with variants in CENPF. | Eur J Hum Genet | 2026 | 42471516 | PubTator, text mining | PubMed |
| Heterogeneity characterization and therapeutic marker discovery of endometrial carcinoma using GeoMXT™ digital spatial profiling. | J Transl Med | 2026 | 42458520 | PubTator, text mining | PubMed |
| Molecular effects of ovarian stimulation for fertility preservation in breast cancer: a paired-biopsy analysis. | ESMO Open | 2026 | 42413327 | PubTator, text mining | PubMed |
| Integrative Transcriptomic Analysis Identifies Hypoxia-responsive Cell Cycle Hub Genes as Prognostic Markers in Glioblastoma. | Ann Neurosci | 2026 | 42405025 | PubTator, text mining | PubMed |
| In silico analysis suggests ELL2 as a survival-associated cross-tissue biomarker in gastric cancer. | Cancer Biomark | 2026 | 42333064 | PubTator, text mining | PubMed |
1 to 10 of 2,501
See all 2,501 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1063
GET https://conductscience.org/api/genes/v1/1063/patents?page=2